End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Jun. 18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
Jun. 03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
Chart calendar Cosmo Pharmaceuticals S.p.A
Upcoming events on Cosmo Pharmaceuticals S.p.A
Past events on Cosmo Pharmaceuticals S.p.A
2024-07-09 | Détachement de for final dividend |
2024-07-05 06:00 am | Extraordinary Shareholders Meeting |
2024-06-05 | ODDO BHF Nextcap Forum |
2024-05-24 06:00 am | Annual General Meeting |
2024-03-20 10:00 am | Investor Day |
2024-03-20 06:00 am | Q4 2023 Earnings Call |
2024-03-20 02:00 am | Q4 2023 Earnings Release |
2024-03-12 | J.P. Morgan Pan-European Small/Mid-Cap CEO Conference |
2024-01-15 | ODDO BHF Forum |
2023-12-04 | CF&B Communication European Midcap Conference |
2023-11-13 | Jefferies London Healthcare Conference |
2023-10-09 | Investor Meeting - Day 2 |
2023-10-08 | Investor Meeting - Day 1 |
2023-07-26 08:00 am | Q2 2023 Earnings Call |
2023-07-26 01:00 am | Q2 2023 Earnings Release |
2023-05-30 | Détachement de for final dividend |
2023-05-26 06:00 am | Annual General Meeting |
2023-03-27 | Jefferies Pan-European Mid-Cap Conference |
2023-03-23 | Kepler Cheuvreux Swiss Seminar |
2023-03-23 09:00 am | Q4 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 62,5 47,1 32.64% | 60,9 53,0 14.94% | 65,1 62,4 4.3% | 102 101 1.31% | 96,7 139 -30.49% | 249 |
EBITDA Million EUR | Released Forecast Spread | -6,55 -12,7 48.58% | 12,9 9,31 38.99% | 18,5 9,21 100.87% | 41,9 39,4 6.34% | 26,5 67,8 -60.94% | 152 |
EBIT Million EUR | Released Forecast Spread | -12,3 -17,5 29.63% | 6,91 3,31 108.93% | 11,1 5,31 109.26% | 28,1 28,7 -2.33% | 12,2 56,3 -78.29% | 150 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -21,3 -28,8 26.11% | -6,93 -7,45 6.97% | 24,0 21,0 14.3% | 24,5 23,7 3.19% | 7,61 63,3 -87.97% | 140 |
Net income Million EUR | Released Forecast Spread | -24,5 -27,6 11.25% | -7,90 -6,47 -22.12% | 21,7 11,3 91.37% | 17,2 21,4 -19.57% | 1,15 34,5 -96.67% | 113 |
EPS EUR | Released Forecast Spread | -1,67 -1,83 8.71% | -0,55 -0,43 -27.57% | 1,29 0,72 77.89% | 1,05 1,12 -6% | 0,07 0,72 -90.07% | 7,60 |
Announcement Date | 03/04/20 | 26/03/21 | 23/03/22 | 23/03/23 | 20/03/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2021 S1 | 2022 S1 | 2022 S2 | 2023 S1 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 41,0 23,3 75.91% | 25,9 22,1 17.38% | 28,4 27,9 2.05% | 41,5 38,7 7.26% | 60,6 58,0 4.44% | 43,7 44,6 -2.11% | 132 | 37,3 | 44,3 | 51,8 | 56,1 |
EBITDA Million EUR | Released Forecast Spread | 8,04 3,70 117.32% | ||||||||||
EBIT Million EUR | Released Forecast Spread | 4,89 -0,90 643.78% | 2,66 -4,20 163.38% | 0,01 0,55 -98.55% | 8,11 3,20 153.38% | 19,9 19,5 2.3% | 7,12 4,90 45.37% | 108 | 12,0 | 17,4 | 23,3 | |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1,32 -8,00 116.44% | -5,33 -8,45 36.91% | -4,67 -6,45 27.64% | 9,09 -1,10 926.27% | 15,4 15,6 -1.38% | 3,67 1,30 182.54% | 109 | 13,0 | 18,4 | 24,3 | |
Net income Million EUR | Released Forecast Spread | -3,71 -6,55 43.33% | -3,02 -8,45 64.32% | -5,74 -6,45 10.99% | 7,90 -1,10 817.82% | 9,33 14,8 -36.97% | 1,49 1,00 48.6% | 78,2 | 9,36 | 13,3 | 17,5 | |
EPS EUR | Released Forecast Spread | -0,26 -0,50 47.6% | -0,21 -0,55 61.9% | -0,40 -0,43 6.12% | 0,48 -0,06 893.33% | 0,57 0,90 -36.33% | 0,09 0,06 53.33% | 4,87 | 0,58 | 0,83 | 1,09 | 1,19 |
Announcement Date | 03/04/20 | 30/07/20 | 30/07/21 | 28/07/22 | 23/03/23 | 26/07/23 | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Cosmo Pharmaceuticals S.p.A
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
- Stock Market
- Equities
- COPN Stock
- Stock
- Calendar Cosmo Pharmaceuticals S.p.A